tradingkey.logo

Azenta Inc

AZTA
View Detailed Chart

31.200USD

+0.740+2.43%
Market hours ETQuotes delayed by 15 min
1.43BMarket Cap
LossP/E TTM

Azenta Inc

31.200

+0.740+2.43%
Intraday
1m
30m
1h
D
W
M
D

Today

+2.43%

5 Days

+6.56%

1 Month

+2.67%

6 Months

-16.73%

Year to Date

-37.60%

1 Year

-36.43%

View Detailed Chart

TradingKey Stock Score

Currency: USD Updated2025-09-17

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
55 / 507
Overall Ranking
159 / 4723
Industry
Biotechnology & Medical Research

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 8 analysts
Hold
Current Rating
31.429
Target Price
+2.74%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Azenta, Inc. is a provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. The Sample Management Solutions segment offers end-to-end sample management products and services, including sample and repository services and core products (automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices). The Multiomics segment provides genomic and other sample analysis services, including gene sequencing and synthesis editing and related services. The B Medical Systems segment is focused on the manufacturing and distribution of temperature-controlled storage and transportation solutions in international markets to governments, health institutions, and non-government organizations. The Company provides products and services through its brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, Barkey, and B Medical Systems.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 18.15% year-on-year.
Undervalued
The company’s latest PE is -161.56, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 54.83M shares, decreasing 7.81% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 4.55M shares of this stock.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Azenta, Inc. is a provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. The Sample Management Solutions segment offers end-to-end sample management products and services, including sample and repository services and core products (automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices). The Multiomics segment provides genomic and other sample analysis services, including gene sequencing and synthesis editing and related services. The B Medical Systems segment is focused on the manufacturing and distribution of temperature-controlled storage and transportation solutions in international markets to governments, health institutions, and non-government organizations. The Company provides products and services through its brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, Barkey, and B Medical Systems.
Ticker SymbolAZTA
CompanyAzenta Inc
CEOMr. John Marotta
Websitehttps://www.azenta.com/
KeyAI